Scolaris Content Display Scolaris Content Display

Joga stosowana łącznie z innymi metodami leczenia w porównaniu z leczeniem standardowym u chorych na schizofrenię

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Isuru 2015 {published data only}

Isuru LL, Dahanayake DMA, de Alwis A, Weerasinghe A, Hewage SN, Ranasinghe CK. Impact of dance, drama, yoga and music therapy workshops on symptom reduction in patients with schizophrenia: A randomized controlled study. South Asian Journal of Psychiatry 2015;3:2, March:1‐7. CENTRAL
SLCTR‐2013‐008 http://trials.slctr.lk/trials/113. Developing social skills, communication skills and self‐confidence through dance, drama and yoga in patients with long term mental illness at NIMH, Angoda. Trial Registry. CENTRAL

Paikkatt 2012 {published data only}

Paikkatt B, Singh AR, Singh PK, Jahan M. Efficacy of yoga therapy on subjective well‐being and basic living skills of patients having chronic schizophrenia. Industrial Psychiatry Journal 2012;21(2):109‐14. [PUBMED: 24250042]CENTRAL
Paikkatt B, Singh AR, Singh PK, Jahan M, Ranjan JK. Efficacy of Yoga therapy for the management of psychopathology of patients having chronic schizophrenia. Indian Journal of Psychiatry 2015;57(4):355‐60. CENTRAL

Xie 2006 {published data only}

Xie J, Lin YH, Guo CR, Chen F. Study on influences of yoga on quality of life of schizophrenic inpatients [瑜伽练习对精神分裂症住院患者生活质量的影响]. Nanfang Journal of Nursing [南方护理学报] 2006;13:9‐10. CENTRAL

References to studies excluded from this review

Behere 2011 {published data only}

Behere RV, Arasappa R, Jagannathan A, Varambally S, Venkatasubramanian G, Thirthalli J, et al. Effect of yoga therapy on facial emotion recognition deficits, symptoms and functioning in patients with schizophrenia. Acta Psychiatrica Scandinavica 2011;123(2):147‐53. [PUBMED: 20846271]CENTRAL

Bhatia 2012 {published data only}

Bhatia T, Agarwal A, Shah G, Wood J, Richard J, Gur RE, et al. Adjunctive cognitive remediation for schizophrenia using yoga: an open, non‐randomized trial. Acta Neuropsychiatrica 2012;24(2):91‐100. CENTRAL

Bhatia 2017 {published data only}

Bhatia T, Mazumdar S, Mishra NN, Gur RE, Gur RC, Nimgaonkar VL, et al. Protocol to evaluate the impact of yoga supplementation on cognitive function in schizophrenia: a randomised controlled trial. Acta Neuropsychiatrica 2014;26(5):280‐90. [PUBMED: 25241756]CENTRAL
Bhatia T, Mazumdar S, Wood J, Fanyin H, Gur RE, Gur R, et al. Adjunctive yoga or physical exercise can enhance cognitive functions among persons with schizophrenia. Schizophrenia Bulletin 2015;41:S69. CENTRAL
Bhatia T, Mazumdar S, Wood J, He F, Gur RE, Gur RC, et al. A randomised controlled trial of adjunctive yoga and adjunctive physical exercise training for cognitive dysfunction in schizophrenia. Acta Neuropsychiatrica 2017;29(2):102‐14. [PUBMED: 27514629]CENTRAL
Bhatia T, Mazumdar S, Wood J, He F, Gur RE, Gur RC, et al. Cognitive remediation with yoga for patients with schizophrenia. Neuropsychopharmacology 2015;40:S376. CENTRAL

Duraiswamy 2007 {published data only}

Duraiswamy G, Thirthalli J, Nagendra HR, Gangadhar BN. Yoga therapy as an add‐on treatment in the management of patients with schizophrenia ‐ a randomized controlled trial. Acta Psychiatrica Scandinavica 2007;116(3):226‐32. CENTRAL

Hu 2014 {published data only}

胡光霞, 顾克鹏. 瑜伽练习对长春市某医院精神分裂症住院患者社会功能的影响. 医学与社会 2014;27(2):85‐7. CENTRAL

Ikai 2013 {published data only}

Ikai S, Uchida H, Suzuki T, Tsunoda K, Mimura M, Fujii Y. Effects of yoga therapy on postural stability in patients with schizophrenia‐spectrum disorders: a single‐blind randomized controlled trial. Journal of Psychiatric Research 2013;47(11):1744‐50. [PUBMED: 23932244]CENTRAL

Ikai 2014 {published data only}

Ikai S, Suzuki T, Saruta J, Tsukinoki K, Tani H, Nagai N, et al. Effects of weekly one‐hour hatha yoga therapy on resilience and stress levels in schizophrenia: A randomized controlled eight‐week trial. Schizophrenia Bulletin 2015;41:S315‐6. CENTRAL
Ikai S, Suzuki T, Uchida H, Saruta J, Tsukinoki K, Fujii Y, et al. Effects of weekly one‐hour Hatha yoga therapy on resilience and stress levels in patients with schizophrenia‐spectrum disorders: an eight‐week randomized controlled trial. Journal of Alternative and Complementary Medicine (New York, N.Y.) 2014;20(11):823‐30. [PUBMED: 25364946]CENTRAL

Jayaram 2013 {published data only}

Jayaram N, Varambally S, Behere RV, Venkatasubramanian G, Arasappa R, Christopher R, et al. Effect of yoga therapy on plasma oxytocin and facial emotion recognition deficits in patients of schizophrenia. Indian Journal of Psychiatry 2013;55(Suppl 3):S409‐13. [PUBMED: 24049210]CENTRAL

Kavak 2016 {published data only}

Kavak F, Ekinci M. The effect of yoga on functional recovery level in schizophrenic patients. Archives of Psychiatric Nursing 2016;30(6):761‐7. CENTRAL

Lin 2006 {published data only}

Lin Y, Wang J, Xie J. Effectiveness of yoga alleviating side effects caused by antipsychotic medications [瑜珈健身法减轻抗精神病药物不良反应的效果观察]. Journal of Nursing Science [护理学杂志] 2006;21(3):56‐7. CENTRAL

Lin 2015 {published data only}

Chen EYH, Lin J, Lee EHM, Chang WC, Chan SKW, Hui CLM. Yoga exercise for cognitive impairment in psychotic disorders. Schizophrenia Research 2014;153:S26. CENTRAL
Chen EYH, Lin X, Lam MML, Chan KW, Chang WC, Joe G, et al. The impacts of yoga and aerobic exercise on neuro‐cognition and brain structure in early psychosis‐a preliminary analysis of the randomized controlled clinical trial. Schizophrenia Research 2012;136:S56. CENTRAL
Lin J. The Impacts of Aerobic Exercise and Mind‐Body Exercise (Yoga) on Neuro‐cognition and Clinical Symptoms in Early Psychosis: A Single‐Blind Randomized Controlled Clinical Trial (Dissertation). The University of Hong Kong, 2013. CENTRAL
Lin J. Yoga and exercise in psychosis (YEP). http://ClinicalTrials.gov/show/NCT01207219 [Date Accessed: October 20, 2012]. CENTRAL
Lin J, Chan SK, Lee EH, Chang WC, Tse M, Su WW, et al. Aerobic exercise and yoga improve neurocognitive function in women with early psychosis. NPJ Schizophrenia 2015;1:15047. CENTRAL
Lin J, Geng X, Lee EH, Chan SK, Chang WC, Hui CL, et al. Yoga reduces the brain's amplitude of low‐frequency fluctuations in patients with early psychosis results of a randomized controlled trial. Schizophrenia Research 2017;184:141‐2. CENTRAL
Lin J, Geng X, Su W, Chan KW, Lee EHM, Chang WC, et al. The impacts of yoga on cortical thickness, neural connectivity and cognitive function in early psychosis: Preliminary results from a randomized controlled clinical trial. European Psychiatry 2015;30:789. CENTRAL
Lin J, Lam M, Chiu C, Tse M, Khong PL, Chan C, et al. The impacts of yoga and exercise on neuro‐cognitive function and symptoms in early psychosis. Schizophrenia Bulletin 2011;37:171. CENTRAL
Lin JJ, Lee HM, Chan KW, Chang WC, Su W, Honer WG, et al. The impacts of aerobic exercise and mind‐body exercise (yoga) on neuro‐cognition and clinical symptoms in early psychosis a single‐blind randomized controlled clinical trial. Schizophrenia Research2014; Vol. 153, issue Suppl 1:S260. CENTRAL
Lin JJX, Lee EHM, Chang WC, Chan SKW, Tse M, Phong PL, et al. Aerobic exercise and yoga hold promises for improving neuro‐cognition and symptom in early psychosis. Schizophrenia Bulletin 2015;41:S320. CENTRAL
Pansy CCL. The Long‐Term Effects of Yoga and Aerobic Exercise on Cognitive Function and Clinical Symptoms in Early Psychosis: A Follow‐up Randomized Control Trial (Dissertation). The University of Hong Kong, 2014. CENTRAL

Mahal 1976 {published data only}

Mahal AS, Ramu NG, Chaturvedi DD. A double blind controlled study on the role of Brahmyadiyoga and Tagara in Navonmade (acute schizophrenia). Indian Journal of Psychiatry 1976;18(4):59‐88. CENTRAL
Mahal AS, Ramu NG, Chaturvedi DD. Double blind controlled study of brahmyadiyoga and tagara in the management of various types of unmada (schizophrenia). Indian Journal of Psychiatry 1976;18(4):283‐92. CENTRAL
Ramu MG, Chaturvedi DD, Venkataram BS, Shankara MR, Leelavathy S, Janakiramiah N, et al. A double blind controlled study on the role of brahmyadiyoga and tagara in navonmada (acute schizophrenia). Ayurvedic Management of Unmada (Schizophrenia). New Delhi, India: Central Council for Research in Ayurveda & Siddha, 1999:59‐88. CENTRAL

Manjunath 2013 {published data only}

Manjunath RB, Varambally S, Thirthalli J, Basavaraddi IV, Gangadhar BN. Efficacy of yoga as an add‐on treatment for in‐patients with functional psychotic disorder. Indian Journal of Psychiatry2013; Vol. 55, issue 7 Suppl:S374‐8. CENTRAL

Ramu 1999 {published data only}

Ramu MG, Chaturvedi DD, Venkataram BS, Shankara MR, Leelavathy S, Janakiramiah N, et al. A double blind controlled study on the role of brahmyadiyoga and tagara in jirnomada (chronic schizophrenia). Ayurvedic Management of Unmada (Schizophrenia). Central Council for Research in Ayurveda and Siddha, 1999:77‐88. CENTRAL

Vancampfort 2011 {published data only}

Vancampfort D, De Hert M, Knapen J, Wampers M, Demunter H, Deckx S, et al. State anxiety, psychological stress and positive well‐being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study. Disability and Rehabilitation 2011;33(8):684‐9. [PUBMED: 20718623]CENTRAL

Varambally 2012 {published data only}

Varambally S, Gangadhar BN, Thirthalli J, Jagannathan A, Kumar S, Venkatasubramanian G, et al. Therapeutic efficacy of add‐on yogasana intervention in stabilized outpatient schizophrenia: Randomized controlled comparison with exercise and waitlist. Indian Journal of Psychiatry 2012;54(3):227‐32. [PUBMED: 23226845]CENTRAL

Varambally 2013 {published data only}

CTRI‐2011‐06‐001792. Efficacy of brief yoga programme for caregivers of out‐patients with schizophrenia. http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=2838 [Date Accessed: May 20, 2011]. CENTRAL
Varambally S, Vidyendaran S, Sajjanar M, Thirthalli J, Hamza A, Nagendra HR, et al. Yoga‐based intervention for caregivers of outpatients with psychosis: a randomized controlled pilot study. Asian Journal of Psychiatry 2013;6(2):141‐5. CENTRAL

Visceglia 2011 {published data only}

Visceglia E, Lewis S. Yoga therapy as an adjunctive treatment for schizophrenia: a randomized, controlled pilot study. Journal of Alternative and Complementary Medicine (New York, N.Y.) 2011;17(7):601‐7. [PUBMED: 21711202]CENTRAL

Wu 2014 {published data only}

吴春芳, 王朔, 王文胜. 瑜伽训练对精神分裂症患者个人和社会功能的改善作用. 山东医药 2014;54(7):99‐100. CENTRAL

JPRN‐UMIN000013746 {published data only}

JPRN‐UMIN000013746. Effects study of yoga therapy on the association of mental illness with metabolic disorders, including the carbonyl stress. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=JPRN‐UMIN000013746(accessed March 2015). CENTRAL

Alford 1994

Alford BA, Beck AT. Cognitive therapy of delusional beliefs. Behaviour Research and Therapy 1994;32(3):369‐80. [PUBMED: 8192636]

Altman 1996

Altman DG, Bland JM. Detecting skewness from summary information. BMJ (Clinical research ed.) 1996;313(7066):1200. [PUBMED: 8916759]

Bangalore 2012

Bangalore NG, Varambally S. Yoga therapy for schizophrenia. International Journal of Yoga 2012;5(2):85‐91. [PUBMED: 22869990]

Birchwood 2006

Birchwood M, Trower P. The future of cognitive behavioural therapy for psychosis: not a quasi‐neuroleptic. British Journal of Psychiatry: The Journal of Mental Science 2006;188:107‐8. [PUBMED: 16449695]

Bland 1997

Bland JM, Kerry SM. Statistics notes. Trials randomised in clusters. BMJ (Clinical research ed.) 1997;315(7108):600. [PUBMED: 9302962]

Boissel 1999

Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices, 3: comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'Etude des Indices D'efficacite]. Therapie 1999;54(4):405‐11. [PUBMED: 10667106]

Broderick 2015

Broderick J, Knowles A, Chadwick J, Vancampfort D. Yoga versus standard care for schizophrenia. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: 10.1002/14651858.CD010554.pub2]

Broderick 2016

Broderick J, Crumlish N, Waugh A, Vancampfort D. Yoga versus non‐standard care for schizophrenia. Cochrane Database of Systematic Reviews 2016, Issue 1. [DOI: 10.1002/14651858.CD012052]

Broderick 2017

Broderick J, Vancampfort D. Yoga as part of a package of care versus non‐standard care for schizophrenia. Cochrane Database of Systematic Reviews 2017;9:CD012807.

Büssing 2012

Büssing A, Michalsen A, Khalsa SB, Telles S, Sherman KJ. Effects of yoga on mental and physical health: a short summary of reviews. Evidence‐Based Complementary and Alternative Medicine: eCAM 2012;Epub 2012 Sep 13:165410. [PUBMED: 23008738]

Carbon 2014

Carbon M, Correll CU. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. CNS Spectrums 2014;19 Suppl 1:38‐52; quiz 35‐7, 53. [PUBMED: 25403863]

Caspersen 1985

Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health‐related research. Public Health Reports (Washington, D.C. : 1974) 1985;100(2):126‐31. [PUBMED: 3920711]

Collins 1998

Collins C. Yoga: intuition, preventive medicine, and treatment. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN/NAACOG 1998;27(5):563‐8. [PUBMED: 9773368]

Correll 2015

Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry: Official Journal of the World Psychiatric Association (WPA) 2015;14(2):119‐36. [PUBMED: 26043321]

Cramer 2013

Cramer H, Lauche R, Klose P, Langhorst J, Dobos G. Yoga for schizophrenia: a systematic review and meta‐analysis. BMC Psychiatry 2013;13:32. [PUBMED: 23327116]

Crawford 2007

Crawford MJ, Patterson S. Arts therapies for people with schizophrenia: an emerging evidence base. Evidence‐Based Mental Health 2007;10(3):69‐70. [PUBMED: 17652554]

Damodaran 2002

Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi, Marathe S. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. Journal of the Association of Physicians of India 2002;50(5):633‐40.

Dauwan 2016

Dauwan M, Begemann MJ, Heringa SM, Sommer IE. Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta‐analysis. Schizophrenia bulletin 2016;42(3):588‐99. [PUBMED: 26547223]

Deeks 2000

Deeks J. Issues in the selection for meta‐analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25‐28. Cape Town: The Cochrane Collaboration, 2000.

Deeks 2011

Deeks JJ, Higgins JPT, Altman DG (editors) on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

Divine 1992

Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623‐9. [PUBMED: 1453246]

Donner 2002

Donner A, Klar N. Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine 2002;21(19):2971‐80. [PUBMED: 12325113]

Egger 1997

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical research ed.) 1997;315(7109):629‐34. [PUBMED: 9310563]

Elbourne 2002

Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthington HV, Vaile A. Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140‐9.

Elkins 2005

Elkins G, Rajab MH, Marcus J. Complementary and alternative medicine use by psychiatric inpatients. Psychological Reports 2005;96(1):163‐6. [PUBMED: 15825920]

Feifel 2011

Feifel D. Is oxytocin a promising treatment for schizophrenia?. Expert Review of Neurotherapeutics2011; Vol. 11, issue 2:157‐9. [PUBMED: 21306203]

Furukawa 2006

Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(1):7‐10. [PUBMED: 16360555]

Fusar‐Poli 2015

Fusar‐Poli P, Papanastasiou E, Stahl D, Rocchetti M, Carpenter W, Shergill S, et al. Treatments of negative symptoms in schizophrenia: meta‐analysis of 168 randomized placebo‐controlled trials. Schizophrenia Bulletin 2015;41(4):892‐9. [PUBMED: 25528757]

Geretsegger 2017

Geretsegger M, Mössler KA, Bieleninik Ł, Chen XJ, Heldal TO, Gold C. Music therapy for people with schizophrenia and schizophrenia‐like disorders. Cochrane Database of Systematic Reviews 2017, Issue 5. [DOI: 10.1002/14651858.CD004025.pub4]

Global Burden of Disease 2015

Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990‐2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386(9995):743‐800.

Gulliford 1999

Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149(9):876‐83. [PUBMED: 10221325]

Higgins 2003

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ (Clinical research ed.) 2003;327(7414):557‐60. [PUBMED: 12958120]

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Higgins 2011a

Higgins JPT, Altman DG, Sterne JAC (editors) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

Hutton 2009

Hutton JL. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology 2009;146(1):27‐30. [PUBMED: 19438480]

Jones 2012

Jones C, Hacker D, Cormac I, Meaden A, Irving CB. Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD008712.pub2; PUBMED: 22513966]

Kay 1986

Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986.

Kern 2009

Kern RS, Glynn SM, Horan WP, Marder SR. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophrenia Bulletin 2009;35(2):347‐61. [PUBMED: 19176470]

Kimhy 2015

Kimhy D, Vakhrusheva J, Bartels MN, Armstrong HF, Ballon JS, Khan S, et al. The impact of aerobic exercise on brain‐derived neurotrophic factor and neurocognition in individuals with schizophrenia: a single‐blind, randomized clinical trial. Schizophrenia Bulletin 2015;41(4):859‐68. [PUBMED: 25805886]

Leon 2006

Leon AC, Mallinckrodt CH, Chuang‐Stein C, Archibald DG, Archer GE, Chartier K. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry 2006;59(11):1001‐5. [PUBMED: 16905632]

Leucht 2005

Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of brief psychiatric rating scale scores. British Journal of Psychiatry 2005;187:366‐71. [PUBMED: 16199797]

Leucht 2013

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple‐treatments meta‐analysis. Lancet (London, England) 2013;382(9896):951‐62. [PUBMED: 23810019]

Li 1995

Li LW, Wei H, Young D. The development of the General Quality of Life Inventory. China Mental Health Journal 1995;9:227‐31.

Li 1998

Li L, Young D, Wei H. The relationship between objective life status and subjective life satisfaction with quality of life. Behavioral Medicine 1998;23(4):149‐59.

Marshall 2000

Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249‐52.

McGrath 2008

McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews 2008;30:67‐76. [PUBMED: 18480098]

Moher 2001

Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomized trials. JAMA 2001;285(15):1987‐91.

Nielsen 2015

Nielsen RE, Levander S, Kjaersdam Telleus G, Jensen SO, Ostergaard Christensen T, Leucht S. Second‐generation antipsychotic effect on cognition in patients with schizophrenia ‐ a meta‐analysis of randomized clinical trials. Acta Psychiatrica Scandinavica 2015;131(3):185‐96. [PUBMED: 25597383]

Overall 1962

Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799‐812.

Owen 2016

Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet (London, England) 2016;388(10039):86‐97. [PUBMED: 26777917]

Payne 2006

Payne H. Dance Movement Therapy ‐ Theory, Research and Practice. 2nd Edition. Sussex: Routledge, 2006.

Ren 2013

Ren J, Xia J. Dance therapy for schizophrenia. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD006868.pub3; PUBMED: 24092546]

Rolvsjord 2001

Rolvsjord R. Sophie learns to play her songs of tears: a case study exploring the dialectics between didactic and psychotherapeutic music therapy practices. Nordic Journal of Music Therapy 2001;10(1):77‐85.

Ross 2012

Ross A, Friedmann E, Bevans M, Thomas S. Frequency of yoga practice predicts health: results of a national survey of yoga practitioners. Evidence‐Based Complementary and Alternative Medicine: eCAM 2012;2012:983258. [PUBMED: 22927885]

Schünemann 2011

Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al on behalf of the Cochrane Applicability and Recommendations Methods Group. Chapter 12: interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www. handbook.cochrane.org2011.

Sherman 2012

Sherman KJ. Guidelines for developing yoga interventions for randomized trials. Evidence‐Based Complementary and Alternative Medicine: eCAM 2012;2012:143271. [PUBMED: 23082079]

Solli 2008

Solli HP. “Shut up and play!” Improvisational use of popular music for a man with schizophrenia. Nordic Journal of Music Therapy 2008;17(1):67‐77.

Sterne 2011

Sterne JAC, Egger M, Moher D (editors) on behalf of the Cochrane Bias Methods Group. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

Tandon 2013

Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, et al. Definition and description of schizophrenia in the DSM‐5. Schizophrenia Research 2013;150(1):3‐10. [PUBMED: 23800613]

Tarrier 1993

Tarrier N, Beckett R, Harwood S, Baker A, Yusupoff L, Ugarteburu I. A trial of two cognitive‐behavioural methods of treating drug‐resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry 1993;162:524‐32. [PUBMED: 8481745]

Ukoumunne 1999

Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG. Methods for evaluating area‐wide and organisation‐based interventions in health and health care: a systematic review. Health Technology Assessment 1999;3(5):iii‐92. [PUBMED: 10982317]

van Os 2009

van Os J, Kapur S. Schizophrenia. Lancet 2009;374(9690):635‐45. [PUBMED: 19700006]

Vancampfort 2012

Vancampfort D, Vansteelandt K, Scheewe T, Probst M, Knapen J, De Herdt A, et al. Yoga in schizophrenia: a systematic review of randomised controlled trials. Acta Psychiatrica Scandinavica 2012;126(1):12‐20. [PUBMED: 22486714]

Vancampfort 2014

Vancampfort D, Probst M, De Hert M, Soundy A, Stubbs B, Stroobants M, et al. Neurobiological effects of physical exercise in schizophrenia: a systematic review. Disability and Rehabilitation 2014;36(21):1749‐54. [PUBMED: 24383471]

Vancampfort 2015

Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis. World Psychiatry: Official Journal of the World Psychiatric Association (WPA) 2015;14(3):339‐47. [PUBMED: 26407790]

Verma 1989

Verma SK, Verma A. Manual for PGI general well‐being measure. Lucknow: Ankur Psychological Agency1989.

Xia 2009

Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El‐Sayeh H, et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254‐7.

References to other published versions of this review

Broderick 2016a

Broderick J, Crumlish N, Vancampfort D. Yoga as part of a package of care versus standard care for schizophrenia. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD012145]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Isuru 2015

Methods

Allocation: randomised.
Blinding: single‐blind.
Duration: 3 weeks.
Design: parallel.
Setting: inpatients at the National Institute of Mental Health, Angoda, Sri Lanka.

Participants

Diagnosis: schizophrenia (according to the ICD‐10 criteria).
History: participants receiving 'in‐ward treatment', sample randomly chosen from admission registers in each ward.
N=73*.
Age: mean (SD) age of test and control group respectively; 38.79 (9.5) and 41.92 (‐9.82) years**.
Sex: 'majority' 76.7% males***
Inclusion criteria: patients with a clinical diagnosis of schizophrenia made by a Consultant Psychiatrist using WHO criteria, individuals who are receiving treatment from psychiatry wards in a large psychiatric hospital, living in the community, receiving psychiatric treatment due to a court order, ''stable mental state'' following treatment.

Exclusion criteria: learning disability, physical disabilities, critical medical conditions, late onset schizophrenia and whose primary diagnosis was directly linked to substance abuse.

Interventions

1.Yoga package: drama, music, dance and yoga therapies were incorporated into a 'comprehensive program', for 6 hours per day, conducted over a period of 3 weeks, and conducted on 8 days over this period, conducted by instructors from the 'Abhina Academy of Performing Arts, Sri Lanka'. Specific interventions employed were 'breathing control training, identification and correct interpretation of basic emotions, observation of others behaviour and mimicking, attention enhancing procedures, maintaining correct body posture' (N=33).

2. Standard care: received standard care including medication and occupational therapy activities (N=40).

Participants in both groups continued on pharmacotherapy.

Outcomes

Leaving the study early.

Unable to use

Mental state: PANSS ‐ only median (IQR) reported for this data as non‐normally distributed

Self‐esteem: RSES ‐ no data reported

Satisfaction: 'pre‐tested' questionnaire ‐ no data reported

Notes

*20 of the participants were admitted for treatment under court orders to the forensic psychiatry unit of the hospital, **age range not stated, ***exact number not specified

For declaration of interest: 'none' indicated by authors.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: Patients were "randomly allocation"

Response: Sequence generation was not specified.

Allocation concealment (selection bias)

Unclear risk

Concealment strategy was not described.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No details specified.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Quote: "Investigators assessing the outcome measures were blind to the treatment modality employed"

Response: Low risk

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No withdrawals reported in this study, appears to be low risk.

Selective reporting (reporting bias)

High risk

No data provided for RSES or satisfaction measures.

Paikkatt 2012

Methods

Allocation: randomised.
Blinding: not reported.
Duration: 1 month.
Design: parallel.
Setting: inpatients of the Ranchi Institute of Neuro‐Psychiatry and Allied Sciences, Kanke, Ranchi, India.

Participants

Diagnosis: schizophrenia (according to the ICD‐10 criteria).
History: ''chronic'' schizophrenia patients with a minimum duration of illness of 2 years.
N=30.
Age: 20 ‐ 50 years.
Sex: 30M,0F
Inclusion criteria: male, aged 20‐50 years, minimum primary education, diagnosed with ICD‐10 with a minimum illness duration of 2 years, mild to moderate PANSS.

Exclusion criteria: Major physical problems, organic mental disorder, co‐morbid psychiatric disorder, history suggestive of MR, epilepsy, head injury, concurrent active medical disorder and active psychopathology that interfere with following and understanding instructions, history of substance abuse.

Interventions

1.Yoga: 1‐month yoga training with ''motivational and feedback session'' for about 1.5 hours delivered by a trained yoga instructor from the Ranchi Institute. The techniques consisted of the following yoga postures (asanas): (i) standing postures, (ii) lying postures (supine and prone), (iii) sitting postures, (iv) pranayama‐breathing exercises. (N=15).

2. Standard‐care: participants did not receive any add‐on intervention. (N=15).

Participants in both groups continued on pharmacotherapy (participants were on risperidone, and olanzapine with doses regulated according to requirements).

Outcomes

Leaving the study early.

Unable to use

Mental state: PANSS ‐ mean (SD) for individual variable scores only included

General well‐being: PGI general well‐being measure (Hindi version) ‐ mean (SD) for individual variable scores only included

Activities of daily living: checklist for basic living skills ‐ mean (SD) for individual variable scores only included

Disability: Indian disability evaluation and assessment scale: IDEAS ‐ mean (SD) for individual variable scores only included

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Quote: "were randomly assigned"

Response: Unclear risk as method of sequence generation was not specified.

Allocation concealment (selection bias)

Unclear risk

Concealment strategy was not described.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No details provided.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

No details provided.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Although number of participants who dropped out were low (n=1 per group) and balanced between groups, participants who dropped out were not included in the final analysis.

Selective reporting (reporting bias)

High risk

PGI general well‐being measure is a 20‐item scale, but results for only 7 items were reported.

Xie 2006

Methods

Allocation: randomised.
Blinding: not stated.
Duration: 8 weeks.
Design: parallel.
Setting: Mental Health Centre of Shantou University, Shantou, China.

Participants

Diagnosis: schizophrenia (according to the CCMD‐3 criteria).
History: hospitalised chronic schizophrenia patients (course of disease 6.89 ± 2.77 years).
N=90.
Age: yoga group (28.21 ± 8,25), control group (30.45 ± 9.42)*
Sex: 48M, 32F**
Inclusion criteria: controlled symptoms, able to complete questionnaires and participate in treatment.

Exclusion criteria: ''serious body disease'', incorporative patients.

''Normal treatment'' will be given to both groups

Interventions

1.Yoga: 8 weeks yoga training with ''related relaxation exercises'', ''and patients will communicate each other to share their experiences'' with counselling and question and answers session for about 1 hour delivered by two senior nurses with training in ''basic yoga theory''. The yoga consisted of the following elements: (i) ''attention concentrating'', (ii) ''breathe adjusting'', (iii) simple meditation. Yoga progressed in terms of dosage and complexity once ''basic rules'' were mastered (N=46).

2. Standard‐care control: participants did not receive any add‐on intervention (N=42).

Participants in both groups continued on pharmacotherapy.

Outcomes

Quality of life: GQOLI‐74.
Leaving the study early.

Notes

*age range not supplied, **gender of 10 people who left early not detailed,

Study took place July‐Nov 2005.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Quote: ''following the tossing coin method we randomly divided..''

Response: likely to be adequate

Allocation concealment (selection bias)

Unclear risk

No details provided

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

No details provided

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

No details provided

Incomplete outcome data (attrition bias)
All outcomes

High risk

Quote: ''there are 10 cases being dropped (8 cases from yoga group and 2 cases from normal control''

Response: High risk of bias as unbalanced drop‐outs which were not included in analysis.

Selective reporting (reporting bias)

Low risk

All stated outcomes appeared to be reported.

Other bias

Unclear risk

Original paper in Chinese, relied on a translation.

CCMD‐3: Chinese Classification of Mental Disorders
GQOLI‐74: General Quality of Life Inventory‐74
ICD‐10: International Classification of Mental and Behavioural Disorders
IDEAS: Indian Disability Evaluation and Assessment Scale
IQR: interquartile range
MR: mental retardation
PANSS: Positive and Negative Syndrome Scale
PGI: Post Graduate Institute
RSES: Rosenberg Self Esteem Score
SD: Standard deviation

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Behere 2011

Allocation: randomised.

Participants: people with schizophrenia.

Intervention: yoga as a stand alone entity, not as part of a package of care versus exercise and treatment as usual.

Bhatia 2012

Allocation: not randomised.

Bhatia 2017

Allocation: randomised.

Participants: people with schizophrenia.

Intervention: yoga as a stand alone entity, not as part of a package of care versus exercise and treatment as usual.

Duraiswamy 2007

Allocation: randomised.

Participants: people with schizophrenia.

Interventions: yoga as a stand alone entity, not as part of a package of care versus exercise.

Hu 2014

Allocation: randomised.

Participants: people with schizophrenia.

Interventions: yoga as a stand alone entity, not as part of a package of care versus exercise.

Ikai 2013

Allocation: randomised.

Participants: people with schizophrenia.

Intervention: yoga plus regular day care programme versus standard care consisting of regular day care programme not yoga as part of a package of care versus standard care.

Ikai 2014

Allocation: randomised.

Participants: people with schizophrenia.

Intervention: yoga plus regular day care programme versus standard care consisting of regular day care programme not yoga as part of a package of care versus standard care.

Jayaram 2013

Allocation: randomised.

Participants: people with schizophrenia.

Interventions: yoga as a stand alone entity, not as part of a package of care versus ''A simple exercise''.

Kavak 2016

Allocation: 'quasi' randomised not randomised as stated in protocol.

Lin 2006

Allocation: randomised.

Participants: people with schizophrenia.

Interventions: yoga as a stand alone entity, not as part of a package of care versus standard care.

Lin 2015

Allocation: randomised.

Participants: people with schizophrenia.

Interventions: yoga as a stand alone entity, not as part of a package of care versus standard care.

Mahal 1976

Allocation: ''double blind''.

Participants: people with schizophrenia.

Interventions: "Tagara" (local drug with antipsychotic properties) and "Brahmyadiyoga" (an herbal compound) versus chlorpromazine versus placebo, not yoga as part of a package of care.

Manjunath 2013

Allocation: randomised.

Participants: people with schizophrenia or related disorders.

Interventions: yoga as a stand alone entity, not as part of a package of care versus exercise therapy.

Ramu 1999

Allocation: ''double blind''.

Participants: people with schizophrenia.

Interventions: "Tagara" (local drug with antipsychotic properties) and "Brahmyadiyoga" (an herbal compound) versus chlorpromazine versus placebo, not yoga as part of a package of care.

Vancampfort 2011

Allocation: treatments randomised.

Participants: people with schizophrenia.

Intervention: yoga and aerobic exercise performed, but results present effect of a single session of yoga or aerobic exercise separately, rather than effect of cumulative package.

Varambally 2012

Allocation: randomised.

Participants: people with schizophrenia.

Intervention: yoga as a stand alone entity, not as part of a package of care versus standard care control.

Varambally 2013

Allocation: randomised.

Participants: caregivers of people with schizophrenia, not people with schizophrenia.

Visceglia 2011

Allocation: randomised.

Participants: people with schizophrenia.

Intervention: yoga as a stand alone entity, not as part of a package of care versus standard care control.

Wu 2014

Allocation: participants randomly selected but not randomly allocated to intervention/control group.

Characteristics of ongoing studies [ordered by study ID]

JPRN‐UMIN000013746

Trial name or title

Effects study of yoga therapy on the association of mental illness with metabolic disorders

Methods

Allocation: randomised.

Blinding: no details given.

Duration: no details given.

Design: parallel.

Setting: Toyko Metropolitan Matsuzawa Hospital.

Participants

Diagnosis: schizophrenia (DSM IV).
History: no details given.
N=60 (target sample size).
Age: 18‐65 years.
Sex: males and females.
Inclusion criteria: males and females between 18 and 65 years diagnosed with schizophrenia according to DSM‐IV, patients with consent capacity.

Exclusion criteria: patients with diabetes, renal failure, pervasive development disorders, mental retardation.

Interventions

1. Yoga therapy: (no further details given).

2. 'A simple exercise': (no further details given).

Outcomes

Oxidative‐stress markers (no further outcomes listed).

Starting date

05 December 2014.

Contact information

Masanari Itokawa (itokawa‐[email protected]), Hiromi Idozawa (Chiken‐[email protected])

Notes

Contacted for study information 16.02.16, no reply.

DSM IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

Data and analyses

Open in table viewer
Comparison 1. Yoga package versus standard care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mental state: 1. Average score (PANSS, low = good) Show forest plot

Other data

No numeric data

Analysis 1.1

Study

Variable

Yoga package, median (interquartile range)

(n = 33)

Control (median, interquartile range)

(n = 40)

Isuru 2015

PANSS positive

15.0 (10.0 to 17.5)

16.0 (14.0 to 18.0)

Isuru 2015

PANSS negative

17.0 (11.0 to 22.5)

18.0 (15.0 to 22.0)

Isuru 2015

PANSS total

61.0 (49.5 to 72.0)

63.5 (54.5 to 72.8)



Comparison 1 Yoga package versus standard care, Outcome 1 Mental state: 1. Average score (PANSS, low = good).

2 Global state: General well‐being: not improved (PGI general well‐being measure, low = good) Show forest plot

Other data

No numeric data

Analysis 1.2

Study

Sub‐sections

Yoga Package

(n = 14)

Control

(n = 14)

Paikkatt 2012

Not feeling happiness

0

9

Paikkatt 2012

Not feeling satisfied

4

4

Paikkatt 2012

Inadequate sleep

2

2

Paikkatt 2012

Feeling good

1

7

Paikkatt 2012

Not in control of anger

1

3

Paikkatt 2012

Not feeling worthy

1

7

Paikkatt 2012

Not feeling healthy

0

4



Comparison 1 Yoga package versus standard care, Outcome 2 Global state: General well‐being: not improved (PGI general well‐being measure, low = good).

3 Quality of life: Average end‐point score (GQOLI‐74, high = good) short term Show forest plot

1

80

Mean Difference (IV, Fixed, 95% CI)

22.93 [19.74, 26.12]

Analysis 1.3

Comparison 1 Yoga package versus standard care, Outcome 3 Quality of life: Average end‐point score (GQOLI‐74, high = good) short term.

Comparison 1 Yoga package versus standard care, Outcome 3 Quality of life: Average end‐point score (GQOLI‐74, high = good) short term.

4 Leaving the study early: any reason (low = good) short term Show forest plot

3

193

Risk Difference (M‐H, Fixed, 95% CI)

0.06 [‐0.01, 0.13]

Analysis 1.4

Comparison 1 Yoga package versus standard care, Outcome 4 Leaving the study early: any reason (low = good) short term.

Comparison 1 Yoga package versus standard care, Outcome 4 Leaving the study early: any reason (low = good) short term.

5 Activities of daily living (Checklist for basic living skills, low=good) Show forest plot

1

Risk Difference (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 1.5

Comparison 1 Yoga package versus standard care, Outcome 5 Activities of daily living (Checklist for basic living skills, low=good).

Comparison 1 Yoga package versus standard care, Outcome 5 Activities of daily living (Checklist for basic living skills, low=good).

5.1 bathing ‐ does not clean all parts of the body

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.57 [‐0.84, ‐0.30]

5.2 eating habit ‐ does not eat sufficient amount

1

28

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.13, 0.13]

5.3 hair care ‐ does not dry hair after washing

1

28

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.13, 0.13]

5.4 house keeping ‐ does not keep bed/clothes neat and tidy

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.57 [‐0.88, ‐0.27]

5.5 nail care ‐ does not keep nails short and clean

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.36 [‐0.70, ‐0.01]

5.6 teeth brushing ‐ does not brush teeth daily

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.43 [‐0.70, ‐0.16]

5.7 toiletting ‐ does not use appropriate place

1

28

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.13, 0.13]

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Study

Variable

Yoga package, median (interquartile range)

(n = 33)

Control (median, interquartile range)

(n = 40)

Isuru 2015

PANSS positive

15.0 (10.0 to 17.5)

16.0 (14.0 to 18.0)

Isuru 2015

PANSS negative

17.0 (11.0 to 22.5)

18.0 (15.0 to 22.0)

Isuru 2015

PANSS total

61.0 (49.5 to 72.0)

63.5 (54.5 to 72.8)

Figuras y tablas -
Analysis 1.1

Comparison 1 Yoga package versus standard care, Outcome 1 Mental state: 1. Average score (PANSS, low = good).

Study

Sub‐sections

Yoga Package

(n = 14)

Control

(n = 14)

Paikkatt 2012

Not feeling happiness

0

9

Paikkatt 2012

Not feeling satisfied

4

4

Paikkatt 2012

Inadequate sleep

2

2

Paikkatt 2012

Feeling good

1

7

Paikkatt 2012

Not in control of anger

1

3

Paikkatt 2012

Not feeling worthy

1

7

Paikkatt 2012

Not feeling healthy

0

4

Figuras y tablas -
Analysis 1.2

Comparison 1 Yoga package versus standard care, Outcome 2 Global state: General well‐being: not improved (PGI general well‐being measure, low = good).

Comparison 1 Yoga package versus standard care, Outcome 3 Quality of life: Average end‐point score (GQOLI‐74, high = good) short term.
Figuras y tablas -
Analysis 1.3

Comparison 1 Yoga package versus standard care, Outcome 3 Quality of life: Average end‐point score (GQOLI‐74, high = good) short term.

Comparison 1 Yoga package versus standard care, Outcome 4 Leaving the study early: any reason (low = good) short term.
Figuras y tablas -
Analysis 1.4

Comparison 1 Yoga package versus standard care, Outcome 4 Leaving the study early: any reason (low = good) short term.

Comparison 1 Yoga package versus standard care, Outcome 5 Activities of daily living (Checklist for basic living skills, low=good).
Figuras y tablas -
Analysis 1.5

Comparison 1 Yoga package versus standard care, Outcome 5 Activities of daily living (Checklist for basic living skills, low=good).

Table 3. Design of a future study

Methods

Allocation: randomised (clearly described).
Blinding: single blind (outcomes assessor).
Duration: minimum 1 year.
Design: parallel.
Setting: outpatient and inpatient settings.

Participants

Diagnosis: people with a clinical diagnosis of schizophrenia using DSM‐IV criteria.
History: patients randomised from waiting list and referred to research staff.
N=300
Age: > 18 years.
Sex: males and females.
Inclusion criteria: DSM‐IV diagnosis of schizophrenia, age 18 years or older.
Exclusion criteria: Presence of physical disability or illness that precludes participation in yoga intervention.

Interventions

1. Yoga: the yoga intervention should be clearly described and consist of the following components: (i) shithileekarana vyayama (loosening exercises) for approximately 10 minutes, (ii) yoga postures (asanas) for approximately 20 minutes, (iii) breathing exercises and relaxation techniques for approximately 20 minutes using a manualised protocol, yoga programme for 12 weeks, 3 times weekly, follow‐up at 6 months and 1 year, yoga delivered by a trained yoga instructor, meditation not included.

2. Standard‐care control.

All groups stable pharmacotherapy.

Outcomes

Mental state (binary outcomes).

Relapses (binary outcomes).

Quality of life (binary outcomes).

Disability (binary outcomes).

Activities of daily living (binary outcomes).

Costs: cost of services, cost of care.

Adverse events related to yoga (number and type of injuries).

Service outcomes: days in hospital, time attending outpatient psychiatric clinic.

Notes

Adherence should be logged with participants expected to adhere to 70% to 75% of scheduled sessions.

DSM‐IV:Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

Figuras y tablas -
Table 3. Design of a future study
Summary of findings for the main comparison. Yoga package versus standard care for schizophrenia

Yoga package versus standard care for schizophrenia

Patient or population: patients with schizophrenia
Settings: Hospital inpatients
Intervention: Yoga package versus standard care

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)

Quality of the evidence
(GRADE)

Comments

Assumed risk

Corresponding risk

Control

Yoga package versus standard care

Mental State: clinically important change

No useable mental state data reported.

Social functioning: clinically important change

No study reported on social functioning.

Adverse events: clinically important adverse effect

No study reported on adverse effects.

Quality of life: clinically important change*

Follow‐up: mean 4 weeks

The mean quality of life (GQOLI‐74) in the intervention groups was
22.93 higher
(19.74 to 26.12 higher)

80
(1 study)

⊕⊕⊝⊝
low2

* Clinically important data not available: nearest outcome reported were Average endpoint scores on the GQOLI‐74

Leaving the study early: any reason

Leaving the study early: participants lost to follow‐up ‐ short term (low=good)

Low1

0.06

[‐ 0.01 to 0.13]

193

(3 studies)

⊕⊕⊕⊝
moderate3

800 per 1000

1000 per 1000

(640 to 1000)

Moderate1

900 per 1000

1000 per 1000

(720 to 1000)

High1

1000 per 1000

1000 per 1000

(800 to 1000)

Costs of care: direct and indirect

No study reported direct or indirect costs of care.

Physical health: clinically important change

No study reported on physical health.

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its CI).
CI: Confidence interval; RD: risk difference

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

1 Imprecision: Downgraded one level as a number of participants withdrew from two trials, not accounted for in final analysis.
2 Indirectness: Downgraded two levels as unclear of clinical meaning of scores 19.74 to 26.12, and based on one study only.

3Imprecision: Downgraded one level due to relatively small number of participants included.

Figuras y tablas -
Summary of findings for the main comparison. Yoga package versus standard care for schizophrenia
Table 1. Yoga reviews

Review number

Review Title

Status

1

Yoga versus standard care for schizophrenia

Broderick 2015

2

Yoga versus non‐standard care for schizophrenia

Broderick 2016

3

Yoga as part of a package of care versus standard care

Current review

4

Yoga as part of a package of care versus non‐standard care

Broderick 2017

Figuras y tablas -
Table 1. Yoga reviews
Table 2. Comparisons relevant to other reviews suggested by included, excluded and ongoing studies

Intervention

Plus

Control

Participants

Reference tag

Proposed relevant Cochrane review

Yoga

Nil

Exercise

People with schizophrenia

Bhatia 2017; Duraiswamy 2007; Lin 2015; Manjunath 2013; Varambally 2012; JPRN‐UMIN000013746

Yoga versus non‐standard care for schizophrenia

Counselling

Standard care

Motivational and feedback session

Nil

Caregivers of people with schizophrenia

Varambally 2013

Yoga

Non‐standard care

People with schizophrenia

Isuru 2015; Paikkatt 2012; Vancampfort 2011; Xie 2006

Yoga as part of a package of care versus non‐standard care

Chlorpromazine

Nil

Placebo

Mahal 1976; Ramu 1999

Chlorpromazine versus placebo for schizophrenia

'Tagara' (local drug with antipsychotic properties) and 'Brahmyadiyoga' (an herbal compound)

Nil

Chlorpromazine

Chlorpromazine

versus herbal compounds for schizophrenia

Figuras y tablas -
Table 2. Comparisons relevant to other reviews suggested by included, excluded and ongoing studies
Comparison 1. Yoga package versus standard care

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Mental state: 1. Average score (PANSS, low = good) Show forest plot

Other data

No numeric data

2 Global state: General well‐being: not improved (PGI general well‐being measure, low = good) Show forest plot

Other data

No numeric data

3 Quality of life: Average end‐point score (GQOLI‐74, high = good) short term Show forest plot

1

80

Mean Difference (IV, Fixed, 95% CI)

22.93 [19.74, 26.12]

4 Leaving the study early: any reason (low = good) short term Show forest plot

3

193

Risk Difference (M‐H, Fixed, 95% CI)

0.06 [‐0.01, 0.13]

5 Activities of daily living (Checklist for basic living skills, low=good) Show forest plot

1

Risk Difference (M‐H, Fixed, 95% CI)

Subtotals only

5.1 bathing ‐ does not clean all parts of the body

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.57 [‐0.84, ‐0.30]

5.2 eating habit ‐ does not eat sufficient amount

1

28

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.13, 0.13]

5.3 hair care ‐ does not dry hair after washing

1

28

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.13, 0.13]

5.4 house keeping ‐ does not keep bed/clothes neat and tidy

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.57 [‐0.88, ‐0.27]

5.5 nail care ‐ does not keep nails short and clean

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.36 [‐0.70, ‐0.01]

5.6 teeth brushing ‐ does not brush teeth daily

1

28

Risk Difference (M‐H, Fixed, 95% CI)

‐0.43 [‐0.70, ‐0.16]

5.7 toiletting ‐ does not use appropriate place

1

28

Risk Difference (M‐H, Fixed, 95% CI)

0.0 [‐0.13, 0.13]

Figuras y tablas -
Comparison 1. Yoga package versus standard care